Pancreatic Cancer Research

ResearcherHealth Sciences University of HokkaidoActive in the last 2 years

Yasuhiro Kuramitsu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5007272112. Sources: OpenAlex.

Their work

Papers
29 (first author 10, last author 11)
Trials
0
Grants
0
Labs led
2
Collaborators
23
Papers, trials and grants by year

2011: 4 papers · 2012: 2 papers · 2013: 2 papers · 2014: 3 papers · 2015: 7 papers · 2016: none · 2017: 1 paper · 2018: 2 papers · 2019: none · 2020: 1 paper · 2021: 4 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 29

  1. Casein Kinase 1 Alpha 1 Is Over-expressed in Pancreatic Adenocarcinoma Tissues and Correlates With Shorter Patient Survival. Last author DOI 10.21873/cdp.10584↗
  2. Strong Association Between Higher Expression of Anillin Actin-binding Protein in Pancreatic Adenocarcinoma Tissues and Patient Survival Analyzed With the UALCA… Last author DOI 10.21873/cgp.20555↗
  3. A Marine Carotenoid of Fucoxanthinol Accelerates the Growth of Human Pancreatic Cancer PANC-1 Cells. Co-author DOI 10.1080/01635581.2020.1863994↗
  4. ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis. Last author DOI 10.1038/s41598-021-90077-x↗
  5. The Expression Levels of Vinculin in Pancreatic Cancer Tissues Significantly Correlates With Patient Survival. Last author DOI 10.21873/anticanres.15311↗
  6. Prognostic Significance of Cofilin Isoforms in Patients With Pancreatic Ductal Adenocarcinoma. Last author DOI 10.3389/pore.2021.1609821↗
  7. A standardized extract of cultured Lentinula edodes mycelia downregulates cortactin in gemcitabine-resistant pancreatic cancer cells. Last author DOI 10.3892/ol.2021.12915↗
  8. P. gingivalis Lipopolysaccharide Stimulates the Upregulated Expression of the Pancreatic Cancer-Related Genes Regenerating Islet-Derived 3 A/G in Mouse Pancrea… Co-author DOI 10.3390/ijms21197351↗
  9. CUB Domain-containing Protein 1 (CDCP1) Is Down-regulated by Active Hexose-correlated Compound in Human Pancreatic Cancer Cells. Last author DOI 10.21873/anticanres.12961↗
  10. Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer Cells. Last author DOI 10.21873/invivo.11305↗
  11. PI3K inhibitor LY294002, as opposed to wortmannin, enhances AKT phosphorylation in gemcitabine-resistant pancreatic cancer cells. First author DOI 10.3892/ijo.2016.3804↗
  12. The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through I… First author DOI 10.1007/s11523-015-0370-0↗
  13. Cofilin-phosphatase slingshot-1L (SSH1L) is over-expressed in pancreatic cancer (PC) and contributes to tumor cell migration. First author DOI 10.1016/j.canlet.2015.02.015↗
  14. Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environment. Last author PMID 25770187↗
  15. Comparative proteomic analysis of two stress-management strategies in pancreatic cancer. Last author PMID 25770192↗
  16. Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin action. Co-author PMID 25862846↗
  17. High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells. Co-author PMID 26124331↗
  18. Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer Cells. Last author PMID 26504030↗
  19. Gemcitabine induces poly (ADP-ribose) polymerase-1 (PARP-1) degradation through autophagy in pancreatic cancer. First author DOI 10.1371/journal.pone.0109076↗
  20. Active hexose-correlated compound down-regulates HSP27 of pancreatic cancer cells, and helps the cytotoxic effect of gemcitabine. First author PMID 24403454↗
  21. Active hexose-correlated compound down-regulates sex-determining region Y-box 2 of pancreatic cancer cells. First author PMID 25202061↗
  22. Up-regulation of DDX39 in human pancreatic cancer cells with acquired gemcitabine resistance compared to gemcitabine-sensitive parental cells. Co-author PMID 23898070↗
  23. Human pancreatic cancer cells with acquired gemcitabine resistance exhibit significant up-regulation of peroxiredoxin-2 compared to sensitive parental cells. First author PMID 24222118↗
  24. Proteomic differential display identifies upregulated vinculin as a possible biomarker of pancreatic cancer. First author DOI 10.3892/or.2012.2004↗
  25. Heat-shock protein 27 plays the key role in gemcitabine-resistance of pancreatic cancer cells. Co-author PMID 22641665↗
  26. KNK437 downregulates heat shock protein 27 of pancreatic cancer cells and enhances the cytotoxic effect of gemcitabine. First author DOI 10.1159/000321019↗
  27. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry. Co-author DOI 10.3892/or.2011.1278↗
  28. Differential expression of up-regulated cofilin-1 and down-regulated cofilin-2 characteristic of pancreatic cancer tissues. Co-author DOI 10.3892/or.2011.1447↗
  29. Proteomic differential display analysis for TS-1-resistant and -sensitive pancreatic cancer cells using two-dimensional gel electrophoresis and mass spectromet… First author PMID 21737628↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shajedul Islam · 6 shared papers, 2021–2026 · strength 1.23
  2. Byron Baron · 14 shared papers, 2013–2021 · strength 1.00
  3. Kazuyuki Nakamura · 16 shared papers, 2011–2017 · strength 0.73
  4. Shin-Nosuke Yamashita · 2 shared papers, 2025–2026 · strength 0.52
  5. Yufeng Wang · 11 shared papers, 2012–2017 · strength 0.50
  6. Yoshihiko Maehara · 10 shared papers, 2011–2017 · strength 0.46
  7. Yoshihiro Abiko · 2 shared papers, 2020–2021 · strength 0.27
  8. Masaru Terasaki · 2 shared papers, 2018–2022 · strength 0.21
  9. Keisuke Kuhara · 2 shared papers, 2018–2021 · strength 0.21
  10. Isao Sakaida · 6 shared papers, 2011–2014 · strength 0.20
  11. Masayuki Tokunaga · 3 shared papers, 2015–2018 · strength 0.19
  12. Shigeyuki Suenaga · 5 shared papers, 2012–2014 · strength 0.18
  13. Mami Takahashi · 1 shared paper, 2022 · strength 0.14
  14. Michihiro Mutoh · 1 shared paper, 2022 · strength 0.14
  15. Daichi Hiraki · 1 shared paper, 2020 · strength 0.11
  16. Takuya Shimada · 1 shared paper, 2018 · strength 0.10
  17. Kumiko Taba · 3 shared papers, 2011–2012 · strength 0.08
  18. Shomei Ryozawa · 3 shared papers, 2011–2012 · strength 0.08
  19. Masaaki Oka · 2 shared papers, 2012–2015 · strength 0.08
  20. Junya Nawata · 1 shared paper, 2014 · strength 0.04
  21. Tomio Ueno · 1 shared paper, 2012 · strength 0.03
  22. Nobuaki Suzuki · 1 shared paper, 2012 · strength 0.03
  23. Kanako Yoshida · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.